Key Influencer in the Visceral Pain Market 2025: Notable Surge In Buprenorphine Prescriptions Propels Visceral Pain Market Expansion Driver

What market dynamics are playing a key role in accelerating the growth of the visceral pain market?
The visceral pain market's growth is anticipated to be powered by an increasing need for analgesics. These pain relievers work by reducing or inhibiting the brain's perception of pain signals, providing relief from visceral pain by affecting the nervous system and controlling pain signals from the internal organs. The New England Journal of Medicine, for example, reported in April 2024 that the number of clinicians prescribing buprenorphine had increased to over 53,600 by December 2023, up by 11,500 from December 2022. As a result, the increasing demand for these pain relievers is propelling the expansion of the visceral pain market.

Get Your Visceral Pain Market Report Here:
https://www.thebusinessresearchcompany.com/report/visceral-pain-global-market-report

How will the growth rate of the visceral pain market shape industry trends by 2034?
There has been a notable growth in the market size of visceral pain in the past few years. The market, which is expected to expand from $13.84 billion in 2024 to $14.87 billion in 2025, is projected to have a compound annual growth rate (CAGR) of 7.5%. The increase during the historical period could be ascribed to factors like an aging populace, elevated occurrence of chronic illnesses, advancements in medical research, development of healthcare facilities, and amplified awareness and diagnosis frequencies.

Strong expansion is anticipated in the visceral pain market in the coming years, with its value predicted to reach $18.71 billion in 2029, representing a compound annual growth rate (CAGR) of 5.9%. The predicted expansion during the forecast period is rooted in various factors including technological advances in pain management, the rising preference for non-invasive treatment methods, emerging markets and unexplored potentials, tailored medicine strategies, and the incorporation of digital health solutions. Key trends expected over the forecast period encompass a shift towards multimodal pain management, heightened focus on alternative therapies, the emergence of targeted therapies for specific forms of pain, the expanding influence of telemedicine in pain management, and the use of artificial intelligence in pain evaluation.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13950&type=smp

What trends are poised to drive the future success of the visceral pain market?
Key players in the visceral pain market are focused on developing innovative products like NHE3 Inhibitor that offer credible services to their clients. NHE3 Inhibitors belong to a phylogenetic class of drugs that function by hindering the Sodium-Proton-Exchanger subtype 3 (NHE3) in the gut. Case in point, Ardelyx, an American biopharmaceutical firm, unveiled an NHE3 Inhibitor medicine, IBSRELA, in April 2022. IBSRELA is an innovative approach to treating adults suffering from irritable bowel syndrome, characterised by constipation (IBS-C). It functions by restraining the Sodium-Hydrogen Exchanger 3 (NHE3) in the small intestine and colon. Animal studies have demonstrated that it can alleviate abdominal pain by reducing visceral hypersensitivity and intestinal permeability.

Which primary segments of the visceral pain market are driving growth and industry transformations?
The visceral pain market covered in this report is segmented -

1) By Drug Class: Calcium Channel Blockers, Nonsteroidal Anti-Inflammatory (NSAID), Other Drug Classes
2) By Indications: Interstitial Cystitis, Crohn's, Irritable Bowel, Chronic Prostatitis, Other Indications
3) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:
1) By Calcium Channel Blockers: Dihydropyridines, Non-Dihydropyridines
2) By Nonsteroidal Anti-Inflammatory Drugs (NSAID): Selective COX-2 Inhibitors, Non-Selective NSAIDs
3) By Other Drug Classes: Opioids, Tricyclic Antidepressants (TCAs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13950

North America was the largest region in the visceral pain market in 2024. The regions covered in the visceral pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the influential players reshaping the visceral pain market landscape?
Major companies operating in the visceral pain market report are Walgreens Boots Alliance Inc., Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co.Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Endo International PLC, Grünenthal GmbH, Glenmark Pharmaceuticals Limited, Hisamitsu Pharmaceutical Co. Ltd., Chromocell Corporation, Addex Therapeutics Ltd.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=13950&type=smp

What Is Covered In The Visceral Pain Global Market Report?

•Market Size Forecast: Examine the visceral pain market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the visceral pain market for a structured understanding.
•Key Players Overview: Analyze major players in the visceral pain market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the visceral pain market.
•Segment Contributions: Evaluate how different segments drive overall growth in the visceral pain market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the visceral pain market.
•Industry Challenges: Identify potential risks and obstacles affecting the visceral pain market.
•Competitive Landscape: Review strategic developments in the visceral pain market, including expansions, agreements, and new product launches.

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.